[1]
Ghemlas, I. et al. 2025. Post-Induction Minimal Residual Disease in Pediatric Pre-B-Cell Acute Lymphoblastic Leukemia: A Step Towards Precision Medicine?. Journal of Hematology. 14, 2 (Apr. 2025), 56–65. DOI:https://doi.org/10.14740/jh1375.